Formulation of a novel therapeutic for treating cognitive impairment in patients at-risk for alzheimer's disease-related dementias and vascular contributions to cognitive impairment
Ended Project Grant Awarded Last action
- Award ID
- R43AG069524
- Recipient
-
Proneurogen Inc. UEI CC75K29RDV48
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $439,355
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- Arizona, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $439,355 |
Quick answers
Who received award R43AG069524?
R43AG069524 was awarded to Proneurogen Inc. by National Institute on Aging (National Institutes of Health) on August 15, 2020.
How much is award R43AG069524 worth?
$439,355 has been obligated on R43AG069524.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award